Redpoint Bio Corporation

Equities

RPBC

US7577361030

Biotechnology & Medical Research

Delayed OTC Markets Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-.--%

2013	Redpoint Bio Corporation cancelled the transaction announced on July 16, 2012.	CI
2012	Redpoint Bio Corporation cancelled the acquisition of Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others.	CI

Redpoint Bio Corporation Announces Resignation of F. Raymond Salemme as Member of the Board of Directors, Effective as of January 31, 2012

January 26, 2012 at 12:25 pm

On January 20, 2012, Redpoint Bio Corporation announced resignation of F. Raymond Salemme, Ph.D, as a member of the Board of Directors of the company, effective as of January 31, 2012.

Latest news about Redpoint Bio Corporation

Redpoint Bio Corporation cancelled the transaction announced on July 16, 2012.	13-07-16	CI
Redpoint Bio Corporation cancelled the acquisition of Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others.	12-08-09	CI
Redpoint Bio Corporation announced that it expects to receive $40 million in funding.	12-07-16	CI
Redpoint Bio Corporation entered into an exchange transaction agreement to acquire Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others.	12-06-17	CI
Redpoint Bio Corporation Auditor Raises 'Going Concern' Doubt	12-04-16	CI
Redpoint Bio Corporation Announces Resignation of F. Raymond Salemme as Member of the Board of Directors, Effective as of January 31, 2012	12-01-26	CI

Chart Redpoint Bio Corporation

Duration

Period

More charts

Company Profile

Redpoint Bio Corp is a United States-based company. The Company is engaged in research and development in physical, engineering and life sciences.

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
REDPOINT BIO CORPORATION	-.--%	7.99K
MODERNA, INC.	+16.59%	44.87B
IQVIA HOLDINGS INC.	-10.62%	37.8B
LONZA GROUP AG	+40.49%	37.61B
ALNYLAM PHARMACEUTICALS, INC.	+29.92%	31.32B
CELLTRION, INC.	-9.78%	27.4B
ICON PUBLIC LIMITED COMPANY	+12.34%	26.32B
UNITED THERAPEUTICS CORPORATION	+41.53%	14.07B
MEDPACE HOLDINGS, INC.	+31.49%	12.5B
BIO-TECHNE CORPORATION	-7.40%	11.23B

Other Biotechnology & Medical Research